Treatment with tezepelumab has been effective for sinonasal symptoms in patients with severe, uncontrolled asthma and a ...
What is the concept of “dual loyalty” in the context of carceral health care? “Dual loyalty” is used to describe the ethical conflict that can arise in carceral health care when the ...
Birth-related mortality is a major contributor to the burden of deaths worldwide, especially in low-income countries. The Safer Births Bundle of Care program is a combination of interventions ...
This Double Take video from the New England Journal of Medicine describes a man with recurrent severe diffuse abdominal pain without obvious associated symptoms. Based on a Clinical Problem ...
Many inhalers that are vital for patients with asthma or COPD are associated with societal harms that can worsen the very diseases the products are designed to treat. How can this dilemma be resolved?
Yellow fever vaccine is highly effective with a single dose, but vaccine supply is limited. The minimum dose requirements for seroconversion remain unknown. In this double-blind, randomized ...
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when ...
Dr. Brian Y. Chang (Medicine): A 62-year-old man was admitted to this hospital because of abdominal pain. Two years before the current presentation, postprandial abdominal pain developed.
The WHO advises using fractional doses of the 17D yellow fever vaccine when outbreaks occur during vaccine shortages, but evidence on the immunogenicity of these lower doses is limited. New ...
Supported by Swim Across America, the Simon and Eve Colin Foundation, the Dalton Family Foundation, the American Association for Cancer Research–Stand Up To Cancer Colorectal Cancer Dream Team ...
This is a retrospective study of the history, roentgenology and autopsy pathology when appropriate of all infants with severe respiratory-distress syndrome who required twenty-four hours or more ...
Most patients with extrapancreatic neuroendocrine tumors or pancreatic neuroendocrine tumors eventually have disease progression with available therapies, and new treatments are needed. New ...